ШАЛВИЦ, Роберт (US),ХАРТМАН, Шарлотт (US),БАЧ, Акшай (US),ШАЛВИЦ, Исаия (US),ЯНУШ, Джон (US),ГАРДНЕР, Джозеф (US)
申请号：
RU2019134558
公开号：
RU2019134558A
申请日:
2014.06.04
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.
